If you experience any severe or persistent side effects, its crucial to reach out to your healthcare provider for further guidance
Are there any medical issues that would prevent someone from taking GLP-1s
Figure 2 Dysfunction of GLP-1 and Diseases GLP-1 and AD AD is the most common neurodegenerative disease with an incurable cognitive impairment, but recently hope is proposed due to the development of Biogens monoclonal antibody drug aducanumab (ADU) in the USA
GLP-1 medications do reduce appetite, but they also slow stomach emptying, improve fullness signaling, and help regulate blood sugar by affecting insulin and glucagon pathways
Food-first is a nice default when you can manage it, but a shake that you actually finish beats a meal you cant
Slow and steady titration produces better outcomes than aggressive dose escalation